Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $71

Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $71

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $76 to $71.

July 20, 2022

1 minute read

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $76 to $71.

Akerna Shares Down As Cannabis Tech Co. Converts To Crypto Mining, Sells Its Software Assets To POSaBIT

January 27, 12:05 PM

Akerna Corp. (NASDAQ: KERN) will merge with Gryphon Digital Mining, Inc. in an all-stock deal.

November 11, 1:59 PM

- CNBC

August 4, 1:00 PM

JMP Securities has decided to maintain its Outperform rating of Prothena Corp (NASDAQ:PRTA) and raise its price target…

September 14, 11:56 PM

Major cryptocurrencies experienced a notable surge on Thursday evening following the news of Deutsche Bank’s (NYSE:DB) partnership with Taurus.